NAMPT expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 5.561600E-02 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.925590E-01 |
Normal-vs-Stage2 |
1.017010E-01 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
3.047200E-01 |
Stage1-vs-Stage2 |
2.425200E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
9.215000E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
5.018000E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.514170E-01 |
Normal-vs-AfricanAmerican |
6.849200E-01 |
Normal-vs-Asian |
3.159000E-01 |
Caucasian-vs-AfricanAmerican |
4.762100E-02 |
Caucasian-vs-Asian |
8.768400E-01 |
AfricanAmerican-vs-Asian |
2.347200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.534100E-02 |
Normal-vs-Female |
1.183160E-01 |
Male-vs-Female |
7.809000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
6.072300E-02 |
Normal-vs-Extreme_Weight |
1.543630E-01 |
Normal-vs-Obese |
8.098600E-01 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
2.665600E-01 |
Normal_Weight-vs-Obese |
9.265500E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
2.340600E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.500400E-01 |
Normal-vs-Age(41-60Yrs) |
4.551000E-01 |
Normal-vs-Age(61-80Yrs) |
8.214400E-02 |
Normal-vs-Age(81-100Yrs) |
5.505400E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.742400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.862200E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.059200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.199020E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.971600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.448800E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
9.050400E-01 |
Normal-vs-Grade 3 |
8.950400E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
9.886800E-01 |
Grade 2-vs-Grade 4 |
9.050400E-01 |
Grade 3-vs-Grade 4 |
8.950400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.376650E-01 |
Normal-vs-N1 |
7.328600E-01 |
N0-vs-N1 |
1.768230E-01 |
|
|